RNA interference in the era of nucleic acid therapeutics

Vasant Jadhav(Alnylam Pharmaceuticals (United States)), Akshay Vaishnaw(Alnylam Pharmaceuticals (United States)), Kevin Fitzgerald(Alnylam Pharmaceuticals (United States)), Martin A. Maier(Alnylam Pharmaceuticals (United States))

Nature Biotechnology

February 26, 2024

10.1038/s41587-023-02105-y

Cited by 183

Abstract

Related Papers

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Andrew Fire, Siqun Xu, Mary K. Montgomery et al.|Nature|1998|15.3k

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Sayda M. Elbashir, Jens Harborth, Winfried Lendeckel et al.|Nature|2001|9.4k

The impact of microRNAs on protein output

Daehyun Baek, Judit Villén, Chanseok Shin et al.|Nature|2008|3.6k

Knocking down barriers: advances in siRNA delivery

Kathryn A. Whitehead, Róbert Langer, Daniel G. Anderson|Nature Reviews Drug Discovery|2009|3.1k

An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells

Scott M. Hammond, Emily Bernstein, David Beach et al.|Nature|2000|3k